Author

Anna Pellattiero

Observed name: Pellattiero, Anna

Institution: Veneto Institute of Molecular Medicine

Observed institutions: University of Padua, Veneto Institute of Molecular Medicine

ORCID: 0000-0002-9793-3493

Observed ORCID: 0000-0002-9793-3493

OpenAlex ID: A5001246698

Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1

2020 · Stéphanie Herkenne, Olivier Ek, et al. · Cell Metabolism · 189

The cristae modulator Optic atrophy 1 requires mitochondrial ATP synthase oligomers to safeguard mitochondrial function

2018 · Rubén Quintana-Cabrera, Charlotte Quirin, et al. · Nature Communications · 159

Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line

2023 · Masafumi Noguchi, Susumu Kohno, et al. · Cell Death and Disease · 44

Oxidization of optic atrophy 1 cysteines occurs during heart ischemia-reperfusion and amplifies cell death by oxidative stress

2023 · Martina Semenzato, Mark J. Kohr, et al. · Redox Biology · 25

Small molecule OPA1 inhibitors amplify cytochrome c release and reverse cancer cells resistance to Bcl-2 inhibitors

2025 · Anna Pellattiero, Charlotte Quirin, et al. · Science Advances · 24

Metastatic breast cancer cells are selectively dependent on the mitochondrial cristae-shaping protein OPA1

2025 · Antigoni Diokmetzidou, Aurora Maracani, et al. · Cell Death and Disease · 21

Small-molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia

2025 · Sofia La Vecchia, Saurav Doshi, et al. · Science Advances · 14

Flaming Mitochondria: The Anti-inflammatory Drug Leflunomide Boosts Mitofusins

2018 · Anna Pellattiero, Luca Scorrano · Cell chemical biology · 9

Pharmacological modulation of mitochondrial dynamics: identification of a specific OPA1 inhibitor to enhance apoptotic release of cytochrome c.

2019 · Anna Pellattiero · Padua@research (University of Padova) · 1

Data from: Small molecule OPA1 inhibitors reverse mitochondrial adaptations to overcome therapy resistance in acute myeloid leukemia

2026 · Al-Santli, Wafa, Witkowski, Matthew, et al. · DRYAD

Lead optimization of specific OPA1 inhibitors enhancing cytochrome c release and cell death

2024 · Federico Magrin, Anna Pellattiero, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics

Inhibition of the mitochondrial shaping protein OPA1 restores lung adenocarcinoma cells sensitivity to gefitinib.

2022 · Noguchi Masafumi, Susumu Kohno, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

Development of a New Chemical Inhibitor of OPA1 Activity to Increase Cancer Cell Sensitivity Toward Apoptosis

2018 · Anna Pellattiero, Charlotte Quirin, et al. · Biochimica et Biophysica Acta (BBA) - Bioenergetics

Works count: 13

Citation count: 486

H-index: 8

I10-index: 7